- Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group studyLois Almadrones
Sloan Kettering Cancer Center, New York, NY, USA
Oncol Nurs Forum 31:615-23. 2004..To evaluate the psychometric properties of two adapted scales, one for functional status and one for peripheral neuropathy secondary to neurotoxic chemotherapy...
- Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancerLois Almadrones
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Clin J Oncol Nurs 11:211-6. 2007....
- Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology GroupDavid H Moore
Department of Obstetrics Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA
J Clin Oncol 21:4207-13. 2003..The purpose of this study was to determine whether amifostine (WR-2721) prevents or ameliorates clinically significant (grade 2 to 4) neurotoxicity associated with cisplatin and 3-hour paclitaxel chemotherapy. Materials and..
- Chemotherapy-induced peripheral neuropathyTerri Armstrong
Department of Neuro Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Oncol Nurs Forum 32:305-11. 2005..To review the literature documenting the scope, treatment, and prevention of chemotherapy-induced neuropathy...